Study guide

3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis

Key Takeaways Explain This Topic AI

The Henderson-Hasselbalch equation defines systemic pH as the logarithmic ratio of bicarbonate (metabolic component) to dissolved carbon dioxide (respiratory component, 0.0307 × p C O 2 0.0307 \times pCO_2 0.0307 × pC O 2 ​ ), where a 20:1 ratio maintains physiological pH at 7.40.

Arterial blood gas sampling requires strict anaerobic collection in a lyophilized lithium heparin syringe, immediate room temperature analysis within 30 minutes, and complete evacuation of air bubbles which falsely elevate p O 2 pO_2 p O 2 ​ and pH while reducing p C O 2 pCO_2 pC O 2 ​ .

Electrochemical blood gas quantification relies on three specialized electrodes: the Severinghaus potentiometric electrode for p C O 2 pCO_2 pC O 2 ​ , the Clark polarographic amperometric electrode for p O 2 pO_2 p O 2 ​ , and a glass indicator membrane electrode for pH.

Pulse oximeters cannot distinguish oxyhemoglobin from dyshemoglobins; carboxyhemoglobin (carbon monoxide toxicity) and methemoglobin ( F e 3 + Fe^{3+} F e 3 + state) must be definitively quantified using spectrophotometric multi-wavelength co-oximetry.

Systematic acid-base evaluation requires a three-step protocol: establishing acidemia or alkalemia via arterial pH, determining the primary respiratory or metabolic disturbance, and assessing whether secondary compensation is absent, partial, or fully restored.

Last updated: October 2026

Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis

Acid-base homeostasis is essential for human survival. Cellular enzymatic reactions, protein structural conformations, and cellular membrane potentials function optimally only within a narrow extracellular pH range of 7.35 to 7.45. Arterial blood gas (ABG) analysis is the definitive clinical laboratory tool used to evaluate systemic oxygenation, alveolar ventilation, and acid-base status in acute and critical care settings.

1. The Henderson-Hasselbalch Equation and Acid-Base Physiology

The fundamental buffer system defending extracellular pH is the carbonic acid–bicarbonate buffer system : C O 2 + H 2 O ⇌ Carbonic Anhydrase H 2 C O 3 ⇌ H + + H C O 3 − CO_2 + H_2O \xrightleftharpoons{\text{Carbonic Anhydrase}} H_2CO_3 \rightleftharpoons H^+ + HCO_3^- C O 2 ​ + H 2 ​ O Carbonic Anhydrase ​ H 2 ​ C O 3 ​ ⇌ H + + H C O 3 − ​

Applying the law of mass action to this equilibrium yields the Henderson-Hasselbalch equation : pH = pK ′ + log ⁡ [ Base ] [ Acid ] = 6.10 + log ⁡ [ H C O 3 − ] α × p C O 2 \text{pH} = \text{pK}' + \log \frac{[\text{Base}]}{[\text{Acid}]} = 6.10 + \log \frac{[HCO_3^-]}{\alpha \times pCO_2} pH = pK ′ + lo g [ Acid ] [ Base ] ​ = 6.10 + lo g α × pC O 2 ​ [ H C O 3 − ​ ] ​

Where:

pK ′ \text{pK}' pK ′ is the combined apparent dissociation constant of carbonic acid in plasma at 37 ∘ C 37^\circ\text{C} 3 7 ∘ C , equal to 6.10 6.10 6.10 .

[ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] is the renal (metabolic) component, with a normal mean concentration of 24.0 mmol/L 24.0\text{ mmol/L} 24.0 mmol/L .

α \alpha α is the solubility coefficient of carbon dioxide gas in human plasma at 37 ∘ C 37^\circ\text{C} 3 7 ∘ C , equal to 0.0307 mmol / ( L ⋅ mm Hg ) 0.0307\text{ mmol}/(\text{L}\cdot\text{mm Hg}) 0.0307 mmol / ( L ⋅ mm Hg ) (commonly rounded to 0.03 0.03 0.03 ).

p C O 2 pCO_2 pC O 2 ​ is the partial pressure of carbon dioxide gas, reflecting the pulmonary (respiratory) component, with a normal mean of 40.0 mm Hg 40.0\text{ mm Hg} 40.0 mm Hg .

The product α × p C O 2 \alpha \times pCO_2 α × pC O 2 ​ represents the concentration of dissolved carbon dioxide ( d C O 2 dCO_2 d C O 2 ​ ): d C O 2 = 0.0307 × 40.0 = 1.228 mmol/L dCO_2 = 0.0307 \times 40.0 = 1.228\text{ mmol/L} d C O 2 ​ = 0.0307 × 40.0 = 1.228 mmol/L

Substituting these physiological constants into the equation: pH = 6.10 + log ⁡ ( 24.0 1.20 ) = 6.10 + log ⁡ ( 20 ) = 6.10 + 1.30 = 7.40 \text{pH} = 6.10 + \log \left( \frac{24.0}{1.20} \right) = 6.10 + \log(20) = 6.10 + 1.30 = 7.40 pH = 6.10 + lo g ( 1.20 24.0 ​ ) = 6.10 + lo g ( 20 ) = 6.10 + 1.30 = 7.40

The 20:1 Physiological Ratio

The critical clinical insight of the Henderson-Hasselbalch equation is that absolute concentrations of H C O 3 − HCO_3^- H C O 3 − ​ and p C O 2 pCO_2 pC O 2 ​ do not determine pH; rather, their ratio ( [ H C O 3 − ] / [ d C O 2 ] [HCO_3^-] / [dCO_2] [ H C O 3 − ​ ] / [ d C O 2 ​ ] ) determines blood pH :

Whenever the ratio of [ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] to [ 0.0307 × p C O 2 ] [0.0307 \times pCO_2] [ 0.0307 × pC O 2 ​ ] equals 20:1 , blood pH is exactly 7.40 .

If the ratio drops below 20:1 (due to decreased bicarbonate or increased p C O 2 pCO_2 pC O 2 ​ ), systemic acidemia (pH < 7.35) results.

If the ratio exceeds 20:1 (due to increased bicarbonate or decreased p C O 2 pCO_2 pC O 2 ​ ), systemic alkalemia (pH > 7.45) results.

2. Arterial Blood Gas Reference Ranges at 37°C

Parameter Conventional Reference Interval SI Reference Interval Clinical Significance

pH 7.35 − 7.45 7.35 - 7.45 7.35 − 7.45 [ H + ] = 35 − 45 nmol/L [H^+] = 35 - 45\text{ nmol/L} [ H + ] = 35 − 45 nmol/L Negative logarithm of hydrogen ion activity; critical: < 7.20 <7.20 < 7.20 or > 7.60 >7.60 > 7.60

p C O 2 pCO_2 pC O 2 ​ 35 − 45 mm Hg 35 - 45\text{ mm Hg} 35 − 45 mm Hg 4.7 − 6.0 kPa 4.7 - 6.0\text{ kPa} 4.7 − 6.0 kPa Respiratory component; direct measure of alveolar ventilation

p O 2 pO_2 p O 2 ​ 80 − 100 mm Hg 80 - 100\text{ mm Hg} 80 − 100 mm Hg 10.6 − 13.3 kPa 10.6 - 13.3\text{ kPa} 10.6 − 13.3 kPa Arterial oxygen tension; reflects pulmonary gas exchange efficiency

H C O 3 − HCO_3^- H C O 3 − ​ (Actual) 22 − 26 mmol/L 22 - 26\text{ mmol/L} 22 − 26 mmol/L 22 − 26 mmol/L 22 - 26\text{ mmol/L} 22 − 26 mmol/L Metabolic component; regulated by renal proton excretion and base reabsorption

Total C O 2 CO_2 C O 2 ​ ( t C O 2 tCO_2 tC O 2 ​ ) 23 − 27 mmol/L 23 - 27\text{ mmol/L} 23 − 27 mmol/L 23 − 27 mmol/L 23 - 27\text{ mmol/L} 23 − 27 mmol/L [ H C O 3 − ] + ( 0.0307 × p C O 2 ) [HCO_3^-] + (0.0307 \times pCO_2) [ H C O 3 − ​ ] + ( 0.0307 × pC O 2 ​ )

Oxygen Saturation ( s O 2 sO_2 s O 2 ​ ) > 95 % > 95\% > 95% ( 95 − 98 % 95 - 98\% 95 − 98% ) 0.95 − 0.98 0.95 - 0.98 0.95 − 0.98 Percentage of functional hemoglobin saturated with oxygen

Base Excess (BE) − 2.0 to + 2.0 mmol/L -2.0\text{ to }+2.0\text{ mmol/L} − 2.0 to + 2.0 mmol/L − 2.0 to + 2.0 mmol/L -2.0\text{ to }+2.0\text{ mmol/L} − 2.0 to + 2.0 mmol/L Titratable base when blood is titrated to pH 7.40 at p C O 2 = 40 mm Hg pCO_2 = 40\text{ mm Hg} pC O 2 ​ = 40 mm Hg and 37 ∘ C 37^\circ\text{C} 3 7 ∘ C

Temperature Effects: Blood gas analyzers maintain internal measuring chambers strictly at 37.0 ∘ C 37.0^\circ\text{C} 37. 0 ∘ C . Gas solubility is inversely proportional to temperature. In hypothermic patients (e.g., cardiopulmonary bypass at 28 ∘ C 28^\circ\text{C} 2 8 ∘ C ), physical gas solubility increases; if corrected to actual body temperature, p C O 2 pCO_2 pC O 2 ​ and p O 2 pO_2 p O 2 ​ are lower, and pH is higher than uncorrected values measured at 37 ∘ C 37^\circ\text{C} 3 7 ∘ C . Modern practice recommends reporting uncorrected ( 37 ∘ C 37^\circ\text{C} 3 7 ∘ C ) values for acid-base interpretation (alpha-stat approach).

3. Preanalytical Integrity and Artifact Sources

Arterial blood gas measurements are uniquely vulnerable to preanalytical collection and handling errors. Because clinical decisions based on blood gas results involve ventilator changes and sodium bicarbonate infusions, adherence to stringent preanalytical protocols is mandatory.

Preanalytical Requirements

Anticoagulant: The anticoagulant of choice is lyophilized (dry) electrolyte-balanced lithium heparin ( 10 − 50 USP units/mL 10-50\text{ USP units/mL} 10 − 50 USP units/mL of blood).

Liquid Heparin Error: Liquid heparin introduces a significant dilutional artifact . If a syringe is flushed with liquid sodium or lithium heparin without expelling excess fluid, as little as 10% dilution falsely decreases p C O 2 pCO_2 pC O 2 ​ , falsely decreases total C O 2 CO_2 C O 2 ​ and H C O 3 − HCO_3^- H C O 3 − ​ , and falsely distorts electrolytes. Only dry lyophilized heparin or specialized self-filling syringes should be utilized.

Wrong Anticoagulant: EDTA, citrate, and oxalate cannot be used because their acidic properties alter blood pH, and their sodium or potassium salts disrupt concurrent electrolyte quantification.

Anaerobic Collection: Samples must be collected without any exposure to ambient air.

Air Bubble Contamination: Atmospheric room air at sea level exerts a p O 2 pO_2 p O 2 ​ of ≈ 150 mm Hg \approx 150\text{ mm Hg} ≈ 150 mm Hg and a p C O 2 pCO_2 pC O 2 ​ of ≈ 0.3 mm Hg \approx 0.3\text{ mm Hg} ≈ 0.3 mm Hg . When an air bubble is introduced into an arterial blood gas syringe:

Oxygen diffuses from the bubble into blood, falsely elevating p O 2 pO_2 p O 2 ​ (particularly if the patient's in vivo p O 2 pO_2 p O 2 ​ was < 100 mm Hg <100\text{ mm Hg} < 100 mm Hg ).

Carbon dioxide diffuses from blood into the bubble down its steep concentration gradient, falsely decreasing p C O 2 pCO_2 pC O 2 ​ .

The loss of carbonic acid drives the Henderson-Hasselbalch ratio upward, falsely elevating pH .

Remedy: Phlebotomists must immediately tap the syringe upright, gently express all air bubbles within 5 seconds of needle withdrawal, and hermetically seal the syringe tip with a luer-lock cap.

Sample Transport and Storage:

Cellular elements (erythrocytes, leukocytes, platelets) continue active aerobic and anaerobic glycolysis in vitro, consuming O 2 O_2 O 2 ​ and producing C O 2 CO_2 C O 2 ​ and lactic acid.

If analyzed at room temperature ( 20 − 25 ∘ C 20-25^\circ\text{C} 20 − 2 5 ∘ C ), blood gas analysis must be completed within 30 minutes of collection.

The Ice Slurry Controversy: Historically, specimens were placed in an ice-water slurry ( 0 − 4 ∘ C 0-4^\circ\text{C} 0 − 4 ∘ C ) if analysis was delayed up to 60 minutes to slow cellular metabolism. However, modern arterial syringes are made of polypropylene plastic , which becomes more gas-permeable at freezing temperatures. If plastic syringes are submerged in ice slurry, ambient oxygen slowly penetrates the plastic barrel, falsely elevating p O 2 pO_2 p O 2 ​ . Thus, plastic syringes should be analyzed immediately at room temperature within 30 minutes; immersion in wet ice slurry is reserved exclusively for glass syringes when transport delays up to 60 minutes are unavoidable.

Leukocyte Larceny: In patients with profound leukocytosis (white blood cell count > 50 , 000 − 100 , 000 / μ L >50,000-100,000/\mu\text{L} > 50 , 000 − 100 , 000/ μ L , as in acute myelogenous leukemia), rapid in vitro consumption of oxygen by metabolizing blast cells can drop measured p O 2 pO_2 p O 2 ​ from normal down to profound, life-threatening hypoxemia within minutes ("leukocyte larceny"). In such patients, blood must be placed in a glass syringe on ice or analyzed at the bedside within 2-3 minutes.

4. Electrochemical Measuring Transducers and Co-Oximetry +--------------------------------------------------------------------------------------+

  • | BLOOD GAS SENSOR ARCHITECTURE |
  • +------------------------------------+-------------------------------------------------+
  • | ELECTRODE | OPERATIONAL PRINCIPLE |
  • +------------------------------------+-------------------------------------------------+
  • | pH Electrode | Potentiometric; H+ glass membrane with |
  • | (Sanz Electrode) | internal Ag/AgCl reference and external calomel |
  • +------------------------------------+-------------------------------------------------+
  • | pCO2 Electrode | Potentiometric; Gas-permeable Teflon membrane; |
  • | (Severinghaus Electrode) | CO2 diffuses into NaHCO3, shifting internal pH |
  • +------------------------------------+-------------------------------------------------+
  • | pO2 Electrode | Amperometric / Polarographic; O2 diffuses across|
  • | (Clark Electrode) | polypropylene; reduced at Pt cathode at -0.6 V |
  • +------------------------------------+-------------------------------------------------+
  • | Co-Oximeter | Spectrophotometric; Multi-wavelength absorbance |
  • | (Hemolyzing Spectrophotometer) | measures OxyHb, DeoxyHb, MetHb, and COHb |
  • +------------------------------------+-------------------------------------------------+
  • The pH Glass Electrode (Sanz Electrode)

The pH electrode is a potentiometric cell measuring electrical potential at zero current flow. It features a specialized pH-sensitive glass membrane made of lithium silicate doped with rare-earth metal oxides. Inside the glass tip is an internal reference solution of 0.1 mol/L HCl 0.1\text{ mol/L HCl} 0.1 mol/L HCl contacting an internal Ag/AgCl \text{Ag/AgCl} Ag/AgCl reference wire. The outer surface contacts the patient's blood. An external reference electrode (calomel, Hg/Hg 2 Cl 2 \text{Hg/Hg}_2\text{Cl}_2 Hg/Hg 2 ​ Cl 2 ​ , or Ag/AgCl \text{Ag/AgCl} Ag/AgCl in saturated KCl \text{KCl} KCl ) provides a stable reference potential via a liquid junction. Hydrogen ions exchange with monovalent cations in the hydrated gel layers of the glass, creating a potential difference governed by the Nernst equation (about 61.5 mV 61.5\text{ mV} 61.5 mV per pH unit at the analyzer's 37 ∘ C 37^\circ\text{C} 3 7 ∘ C , versus 59.16 mV 59.16\text{ mV} 59.16 mV at 25 ∘ C 25^\circ\text{C} 2 5 ∘ C ).

The p C O 2 pCO_2 pC O 2 ​ Electrode (Severinghaus Electrode)

The p C O 2 pCO_2 pC O 2 ​ sensor is a modified potentiometric glass pH electrode covered with a gas-permeable Teflon, silicone, or polyethylene membrane . Between the gas-permeable membrane and the glass electrode lies a thin spacer soaked in an aqueous electrolyte solution containing 0.02 mol/L NaHCO 3 0.02\text{ mol/L NaHCO}_3 0.02 mol/L NaHCO 3 ​ and NaCl \text{NaCl} NaCl .

Uncharged, dissolved C O 2 CO_2 C O 2 ​ molecules from the blood diffuse freely across the gas-permeable membrane into the bicarbonate film down their partial pressure gradient (ions like H + H^+ H + cannot cross).

Once inside, C O 2 CO_2 C O 2 ​ hydrates to form carbonic acid, which dissociates and lowers the pH of the thin bicarbonate layer: C O 2 + H 2 O ⇌ H 2 C O 3 ⇌ H + + H C O 3 − CO_2 + H_2O \rightleftharpoons H_2CO_3 \rightleftharpoons H^+ + HCO_3^- C O 2 ​ + H 2 ​ O ⇌ H 2 ​ C O 3 ​ ⇌ H + + H C O 3 − ​

The internal glass electrode measures this localized decrease in pH. The measured potential is inversely proportional to the logarithm of p C O 2 pCO_2 pC O 2 ​ .

The p O 2 pO_2 p O 2 ​ Electrode (Clark Polarographic Electrode)

The Clark electrode is an amperometric (polarographic) sensor measuring current generated by a chemical oxidation-reduction reaction at a constant applied voltage. It consists of a platinum wire cathode and a silver/silver chloride ( Ag/AgCl \text{Ag/AgCl} Ag/AgCl ) anode immersed in an alkaline phosphate-buffered potassium chloride solution behind an oxygen-permeable polypropylene or Teflon membrane.

A constant polarizing voltage of − 0.6 to − 0.8 V -0.6\text{ to }-0.8\text{ V} − 0.6 to − 0.8 V is applied between cathode and anode.

Dissolved oxygen molecules diffuse through the membrane to the platinum cathode, where they are reduced: Cathode: O 2 + 2 H 2 O + 4 e − ⟶ 4 O H − \text{Cathode: } O_2 + 2H_2O + 4e^- \longrightarrow 4OH^- Cathode: O 2 ​ + 2 H 2 ​ O + 4 e − ⟶ 4 O H − Anode: 4 A g + 4 C l − ⟶ 4 A g C l + 4 e − \text{Anode: } 4Ag + 4Cl^- \longrightarrow 4AgCl + 4e^- Anode: 4 A g + 4 C l − ⟶ 4 A g Cl + 4 e −

Reduction of oxygen consumes four electrons per molecule of O 2 O_2 O 2 ​ . The resulting electron flow (current) between anode and cathode is directly proportional to the partial pressure of oxygen ( p O 2 pO_2 p O 2 ​ ) in the specimen.

Multi-Wavelength Co-Oximetry and Dyshemoglobins

Standard non-invasive pulse oximetry ( S p O 2 SpO_2 Sp O 2 ​ ) uses only two wavelengths of light: 660 nm 660\text{ nm} 660 nm (red, where deoxyhemoglobin absorbs strongly) and 940 nm 940\text{ nm} 940 nm (infrared, where oxyhemoglobin absorbs strongly). Standard pulse oximeters assume only two hemoglobin species exist, rendering them incapable of detecting abnormal dyshemoglobins :

Carboxyhemoglobin (COHb): Carbon monoxide binds to hemoglobin with an affinity 200-250 times greater than oxygen, stabilizing the high-affinity relaxed (R) quaternary state and shifting the oxyhemoglobin dissociation curve to the left, preventing oxygen delivery to hypoxic tissues. Because COHb exhibits light absorption at 660 nm 660\text{ nm} 660 nm almost identical to oxyhemoglobin, a conventional pulse oximeter reads falsely normal (98-100%) in lethal carbon monoxide poisoning.

Methemoglobin (MetHb): Iron in the heme moiety is oxidized from the normal ferrous ( F e 2 + Fe^{2+} F e 2 + ) state to the abnormal ferric ( F e 3 + Fe^{3+} F e 3 + ) state, incapable of binding oxygen. Induced by exposure to nitrates, nitrites, aniline dyes, dapsone, or topical local anesthetics (benzocaine, lidocaine). Methemoglobin absorbs equally well at 660 nm 660\text{ nm} 660 nm and 940 nm 940\text{ nm} 940 nm , forcing the calculated ratio toward 1.0, which causes standard pulse oximeters to plateau at a fixed reading of ≈ 85 % \approx 85\% ≈ 85% , regardless of true arterial oxygenation. Treated clinically with intravenous methylene blue .

Sulfhemoglobin (SulfHb): Irreversible sulfur incorporation into the porphyrin ring caused by exposure to sulfonamides or phenacetin; cannot carry oxygen.

Co-oximetry resolves this limitation: the whole blood sample is hemolyzed via ultrasound or chemical surfactant and passed through a multi-wavelength cuvette measuring spectrophotometric absorbance at 4 to 128 discrete wavelengths (e.g., 535 , 585 , 594 , 626 , 668 nm 535, 585, 594, 626, 668\text{ nm} 535 , 585 , 594 , 626 , 668 nm ). Because each hemoglobin species exhibits a unique mathematical absorption spectrum, multi-component linear matrix equations quantify the exact fractional concentration of: Fractional s O 2 = [ O 2 Hb ] [ O 2 Hb ] + [ DeoxyHb ] + [ COHb ] + [ MetHb ] + [ SulfHb ] × 100 % \text{Fractional } sO_2 = \frac{[O_2\text{Hb}]}{[O_2\text{Hb}] + [\text{DeoxyHb}] + [\text{COHb}] + [\text{MetHb}] + [\text{SulfHb}]} \times 100\% Fractional s O 2 ​ = [ O 2 ​ Hb ] + [ DeoxyHb ] + [ COHb ] + [ MetHb ] + [ SulfHb ] [ O 2 ​ Hb ] ​ × 100%

  • 5. Systematic Interpretation of Acid-Base Homeostasis STEPWISE ABG INTERPRETATION
  • |
  • [1] ASSESS pH
  • |
  • +------------------------+------------------------+
  • | |
  • pH < 7.35 pH > 7.45
  • ACIDEMIA ALKALEMIA
  • | |
  • [2] EXAMINE pCO2 & HCO3- [2] EXAMINE pCO2 & HCO3-
  • Primary Disorder Matches Direction Primary Disorder Matches Direction
  • | |
  • +-------------+-------------+ +-------------+-------------+
  • | | | |
  • High pCO2 Low HCO3- Low pCO2 High HCO3-
  • RESPIRATORY METABOLIC RESPIRATORY METABOLIC
  • ACIDOSIS ACIDOSIS ALKALOSIS ALKALOSIS
  • | | | |

[3] ASSESS COMPENSATION: [3] ASSESS: [3] ASSESS: [3] ASSESS:

- Uncompensated: - Uncompensated: - Uncompensated: - Uncompensated:

HCO3- normal pCO2 normal HCO3- normal pCO2 normal

- Partially: - Partially: - Partially: - Partially:

  • HCO3- elevated, pCO2 decreased, HCO3- decreased, pCO2 elevated,
  • pH < 7.35 pH < 7.35 pH > 7.45 pH > 7.45

- Fully: - Fully: - Fully: - Fully:

  • HCO3- elevated, pCO2 decreased, HCO3- decreased, pCO2 elevated,
  • pH 7.35-7.39 pH 7.35-7.39 pH 7.41-7.45 pH 7.41-7.45
  • The Three-Step Algorithmic Method
  • Step 1: Evaluate Arterial pH

pH < 7.35 \text{pH} < 7.35 pH < 7.35 : Acidemia.

pH > 7.45 \text{pH} > 7.45 pH > 7.45 : Alkalemia.

pH 7.35 − 7.45 \text{pH } 7.35 - 7.45 pH 7.35 − 7.45 : Normal; may reflect true homeostasis or a fully compensated mixed acid-base disorder.

Step 2: Determine the Primary Etiological Disturbance

Look at p C O 2 pCO_2 pC O 2 ​ (respiratory) and H C O 3 − HCO_3^- H C O 3 − ​ (metabolic):

If acidemia ( pH < 7.35 \text{pH} < 7.35 pH < 7.35 ) and p C O 2 > 45 mm Hg pCO_2 > 45\text{ mm Hg} pC O 2 ​ > 45 mm Hg , the disorder is Respiratory Acidosis .

If acidemia ( pH < 7.35 \text{pH} < 7.35 pH < 7.35 ) and H C O 3 − < 22 mmol/L HCO_3^- < 22\text{ mmol/L} H C O 3 − ​ < 22 mmol/L , the disorder is Metabolic Acidosis .

If alkalemia ( pH > 7.45 \text{pH} > 7.45 pH > 7.45 ) and p C O 2 < 35 mm Hg pCO_2 < 35\text{ mm Hg} pC O 2 ​ < 35 mm Hg , the disorder is Respiratory Alkalosis .

If alkalemia ( pH > 7.45 \text{pH} > 7.45 pH > 7.45 ) and H C O 3 − > 26 mmol/L HCO_3^- > 26\text{ mmol/L} H C O 3 − ​ > 26 mmol/L , the disorder is Metabolic Alkalosis .

Step 3: Evaluate the Compensatory Status

The secondary compensatory response is mounted by the opposing organ system (lungs compensate for metabolic defects within minutes to hours; kidneys compensate for respiratory defects over 48-72 hours).

Uncompensated: The compensating variable remains completely within its normal reference interval.

Partially Compensated: The compensating variable is altered in the appropriate direction to restore the 20:1 ratio, but the systemic pH has not yet returned to the reference interval ( 7.35 − 7.45 7.35-7.45 7.35 − 7.45 ).

Fully Compensated: The compensating variable has shifted sufficiently to bring arterial pH back into the normal range ( 7.35 − 7.45 7.35-7.45 7.35 − 7.45 ). The primary disorder is identified by which side of 7.40 the pH falls on: pH 7.35 − 7.39 \text{pH } 7.35 - 7.39 pH 7.35 − 7.39 indicates a compensated primary acidosis; pH 7.41 − 7.45 \text{pH } 7.41 - 7.45 pH 7.41 − 7.45 indicates a compensated primary alkalosis.

  • 6. Clinical Etiologies and Compensation Patterns
  • Respiratory Acidosis (Hypercapnia, p C O 2 > 45 mm Hg pCO_2 > 45\text{ mm Hg} pC O 2 ​ > 45 mm Hg )

Pathophysiology: Hypoventilation leading to retention of carbon dioxide.

Etiologies: Central nervous system depression (opioid overdose, barbiturates, general anesthesia), neuromuscular failure (myasthenia gravis, Guillain-Barré syndrome, amyotrophic lateral sclerosis), mechanical chest trauma (flail chest), airway obstruction (foreign body, severe laryngospasm), chronic pulmonary disease (severe COPD, emphysema, severe asthma).

Compensation: Kidneys secrete excess H + H^+ H + ions and retain/generate H C O 3 − HCO_3^- H C O 3 − ​ . Full metabolic compensation requires 2 to 3 days (acute compensation yields Δ H C O 3 − ≈ 1 mmol/L \Delta HCO_3^- \approx 1\text{ mmol/L} Δ H C O 3 − ​ ≈ 1 mmol/L per 10 mm Hg 10\text{ mm Hg} 10 mm Hg rise in p C O 2 pCO_2 pC O 2 ​ ; chronic compensation yields Δ H C O 3 − ≈ 3.5 − 4 mmol/L \Delta HCO_3^- \approx 3.5-4\text{ mmol/L} Δ H C O 3 − ​ ≈ 3.5 − 4 mmol/L per 10 mm Hg 10\text{ mm Hg} 10 mm Hg rise in p C O 2 pCO_2 pC O 2 ​ ).

Respiratory Alkalosis (Hypocapnia, p C O 2 < 35 mm Hg pCO_2 < 35\text{ mm Hg} pC O 2 ​ < 35 mm Hg )

Pathophysiology: Hyperventilation resulting in excessive exhalation of carbon dioxide.

Etiologies: Psychogenic anxiety/panic attack, hypoxia/high altitude, pulmonary embolism, congestive heart failure, severe sepsis/fever, mechanical ventilator hyperventilation, early salicylate overdose (direct pharmacological excitation of the medullary respiratory center).

Compensation: Kidneys decrease tubular H + H^+ H + secretion and excrete H C O 3 − HCO_3^- H C O 3 − ​ into urine (acute compensation yields Δ H C O 3 − ≈ 2 mmol/L \Delta HCO_3^- \approx 2\text{ mmol/L} Δ H C O 3 − ​ ≈ 2 mmol/L per 10 mm Hg 10\text{ mm Hg} 10 mm Hg drop in p C O 2 pCO_2 pC O 2 ​ ; chronic compensation yields Δ H C O 3 − ≈ 5 mmol/L \Delta HCO_3^- \approx 5\text{ mmol/L} Δ H C O 3 − ​ ≈ 5 mmol/L per 10 mm Hg 10\text{ mm Hg} 10 mm Hg drop in p C O 2 pCO_2 pC O 2 ​ ).

Metabolic Acidosis (Hypobicarbonatemia, H C O 3 − < 22 mmol/L HCO_3^- < 22\text{ mmol/L} H C O 3 − ​ < 22 mmol/L )

Pathophysiology: Accumulation of fixed non-volatile acids (HAGMA) or direct loss of bicarbonate buffer (NAGMA).

Etiologies: Diabetic ketoacidosis, lactic acidosis, renal failure, methanol/ethylene glycol toxicity, severe diarrhea, renal tubular acidosis.

Compensation: Central and peripheral chemoreceptors sense decreased pH, stimulating the respiratory center to initiate rapid, deep breathing ( Kussmaul respirations ), blowing off C O 2 CO_2 C O 2 ​ within minutes. Winter's Formula predicts expected compensatory p C O 2 pCO_2 pC O 2 ​ : Expected p C O 2 = 1.5 × [ H C O 3 − ] + 8 ± 2 \text{Expected } pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2 Expected pC O 2 ​ = 1.5 × [ H C O 3 − ​ ] + 8 ± 2

If measured p C O 2 pCO_2 pC O 2 ​ is within the calculated range → \rightarrow → simple metabolic acidosis with appropriate respiratory compensation.

If measured p C O 2 > Expected p C O 2 → pCO_2 > \text{Expected } pCO_2 \rightarrow pC O 2 ​ > Expected pC O 2 ​ → concurrent primary respiratory acidosis (respiratory failure).

If measured p C O 2 < Expected p C O 2 → pCO_2 < \text{Expected } pCO_2 \rightarrow pC O 2 ​ < Expected pC O 2 ​ → concurrent primary respiratory alkalosis.

Metabolic Alkalosis (Hyperbicarbonatemia, H C O 3 − > 26 mmol/L HCO_3^- > 26\text{ mmol/L} H C O 3 − ​ > 26 mmol/L )

Pathophysiology: Loss of hydrogen ions or excessive gain of exogenous bicarbonate/alkali.

Etiologies: Prolonged gastric suctioning or severe protracted vomiting (loss of hydrochloric acid), severe volume contraction with loop/thiazide diuretics (contraction alkalosis), hyperaldosteronism, excessive administration of sodium bicarbonate or antacids (milk-alkali syndrome).

Compensation: Hypoventilation to retain C O 2 CO_2 C O 2 ​ . However, respiratory compensation is physiologically limited: arterial hypoxemia ( p O 2 < 60 mm Hg pO_2 < 60\text{ mm Hg} p O 2 ​ < 60 mm Hg ) activates carotid peripheral chemoreceptors, overriding hypercapnic suppression to maintain baseline oxygenation.

7. Blood Gas Interpretation Summary Grid

Disorder Primary Abnormality Secondary Compensatory Response Expected pH Expected p C O 2 pCO_2 pC O 2 ​ Expected H C O 3 − HCO_3^- H C O 3 − ​

Uncompensated Respiratory Acidosis ↑ p C O 2 \uparrow pCO_2 ↑ pC O 2 ​ None < 7.35 < 7.35 < 7.35 > 45 mm Hg > 45\text{ mm Hg} > 45 mm Hg Normal ( 22 − 26 22-26 22 − 26 )

Partially Compensated Respiratory Acidosis ↑ p C O 2 \uparrow pCO_2 ↑ pC O 2 ​ Renal H C O 3 − HCO_3^- H C O 3 − ​ retention < 7.35 < 7.35 < 7.35 > 45 mm Hg > 45\text{ mm Hg} > 45 mm Hg > 26 mmol/L > 26\text{ mmol/L} > 26 mmol/L

Fully Compensated Respiratory Acidosis ↑ p C O 2 \uparrow pCO_2 ↑ pC O 2 ​ Maximal renal H C O 3 − HCO_3^- H C O 3 − ​ retention 7.35 − 7.39 7.35 - 7.39 7.35 − 7.39 > 45 mm Hg > 45\text{ mm Hg} > 45 mm Hg > 26 mmol/L > 26\text{ mmol/L} > 26 mmol/L

Uncompensated Respiratory Alkalosis ↓ p C O 2 \downarrow pCO_2 ↓ pC O 2 ​ None > 7.45 > 7.45 > 7.45 < 35 mm Hg < 35\text{ mm Hg} < 35 mm Hg Normal ( 22 − 26 22-26 22 − 26 )

Partially Compensated Respiratory Alkalosis ↓ p C O 2 \downarrow pCO_2 ↓ pC O 2 ​ Renal H C O 3 − HCO_3^- H C O 3 − ​ excretion > 7.45 > 7.45 > 7.45 < 35 mm Hg < 35\text{ mm Hg} < 35 mm Hg < 22 mmol/L < 22\text{ mmol/L} < 22 mmol/L

Fully Compensated Respiratory Alkalosis ↓ p C O 2 \downarrow pCO_2 ↓ pC O 2 ​ Maximal renal H C O 3 − HCO_3^- H C O 3 − ​ excretion 7.41 − 7.45 7.41 - 7.45 7.41 − 7.45 < 35 mm Hg < 35\text{ mm Hg} < 35 mm Hg < 22 mmol/L < 22\text{ mmol/L} < 22 mmol/L

Uncompensated Metabolic Acidosis ↓ H C O 3 − \downarrow HCO_3^- ↓ H C O 3 − ​ None < 7.35 < 7.35 < 7.35 Normal ( 35 − 45 35-45 35 − 45 ) < 22 mmol/L < 22\text{ mmol/L} < 22 mmol/L

Partially Compensated Metabolic Acidosis ↓ H C O 3 − \downarrow HCO_3^- ↓ H C O 3 − ​ Hyperventilation (blows off C O 2 CO_2 C O 2 ​ ) < 7.35 < 7.35 < 7.35 < 35 mm Hg < 35\text{ mm Hg} < 35 mm Hg < 22 mmol/L < 22\text{ mmol/L} < 22 mmol/L

Fully Compensated Metabolic Acidosis ↓ H C O 3 − \downarrow HCO_3^- ↓ H C O 3 − ​ Maximal respiratory compensation 7.35 − 7.39 7.35 - 7.39 7.35 − 7.39 < 35 mm Hg < 35\text{ mm Hg} < 35 mm Hg < 22 mmol/L < 22\text{ mmol/L} < 22 mmol/L

Uncompensated Metabolic Alkalosis ↑ H C O 3 − \uparrow HCO_3^- ↑ H C O 3 − ​ None > 7.45 > 7.45 > 7.45 Normal ( 35 − 45 35-45 35 − 45 ) > 26 mmol/L > 26\text{ mmol/L} > 26 mmol/L

Partially Compensated Metabolic Alkalosis ↑ H C O 3 − \uparrow HCO_3^- ↑ H C O 3 − ​ Hypoventilation (retains C O 2 CO_2 C O 2 ​ ) > 7.45 > 7.45 > 7.45 > 45 mm Hg > 45\text{ mm Hg} > 45 mm Hg > 26 mmol/L > 26\text{ mmol/L} > 26 mmol/L

Fully Compensated Metabolic Alkalosis ↑ H C O 3 − \uparrow HCO_3^- ↑ H C O 3 − ​ Maximal respiratory compensation 7.41 − 7.45 7.41 - 7.45 7.41 − 7.45 > 45 mm Hg > 45\text{ mm Hg} > 45 mm Hg > 26 mmol/L > 26\text{ mmol/L} > 26 mmol/L